These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8801857)

  • 41. Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity.
    Van Damme P; Matheï C; Thoelen S; Meheus A; Safary A; André FE
    J Med Virol; 1994 Dec; 44(4):435-41. PubMed ID: 7897376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Vaccination against hepatitis A].
    Balli F; Di Biase AR; Viola L
    Pediatr Med Chir; 1996; 18(3):259-62. PubMed ID: 8966125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination.
    Saab S; Martin P; Yee HF
    Am J Med; 2000 Aug; 109(3):241-4. PubMed ID: 10974188
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis A vaccine for secondary hepatitis A infection.
    Beutels P; Van Damme P
    Lancet; 1999 Jul; 354(9175):340-1; author reply 342-3. PubMed ID: 10440342
    [No Abstract]   [Full Text] [Related]  

  • 46. Licensure of inactivated hepatitis A vaccine and recommendations for use among international travelers.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Jul; 44(29):559-60. PubMed ID: 7616951
    [No Abstract]   [Full Text] [Related]  

  • 47. [Costs of hepatitis A prophylaxis in travelers].
    Zaaijer HL; Lelie PN
    Ned Tijdschr Geneeskd; 1994 May; 138(19):948-9. PubMed ID: 8196787
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later.
    Briem H; Safary A
    J Med Virol; 1994 Dec; 44(4):443-5. PubMed ID: 7897378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pancreatitis following hepatitis A vaccination.
    Haviv YS; Sharkia M; Galun E; Safadi R
    Eur J Med Res; 2000 May; 5(5):229-30. PubMed ID: 10806126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis A vaccine set for 2-year-olds to adults.
    Marwick C
    JAMA; 1995 Mar 22-29; 273(12):906-7. PubMed ID: 7884933
    [No Abstract]   [Full Text] [Related]  

  • 51. [Current status of immunization in the Armed Forces: need of continuous adaptation of vaccinations against cerebrospinal meningitis, typhoid and hepatitis A].
    Meyran M; Buisson Y; Desfontaine M
    Ann Gastroenterol Hepatol (Paris); 1994 Oct; 30(5):227-31. PubMed ID: 7802441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Supplementary statement on hepatitis A prevention.
    Can Commun Dis Rep; 1996 Jan; 22(1):1-3. PubMed ID: 8825660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis A outbreak in a socially-contained religious community in rural southern Ontario.
    Hockin J; Isaacs S; Kittle D; Brimmer G; Bailey N; Tamblyn S
    Can Commun Dis Rep; 1997 Nov; 23(21):161-6. PubMed ID: 9397602
    [No Abstract]   [Full Text] [Related]  

  • 54. [Vaccination against hepatitis A].
    Zamir D; Zamir H; Weiner P
    Harefuah; 1998 Aug; 135(3-4):114-8. PubMed ID: 9885656
    [No Abstract]   [Full Text] [Related]  

  • 55. Field evaluation of a hepatitis A vaccine in a Norwegian contingent to the United Nations Interim Force in Lebanon.
    Aarhaug P
    Vaccine; 1992; 10 Suppl 1():S156-8. PubMed ID: 1335651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CDC sets interim strategy for hepatitis A control.
    Am J Health Syst Pharm; 1997 Mar; 54(6):625. PubMed ID: 9377216
    [No Abstract]   [Full Text] [Related]  

  • 57. Hepatitis A: the vaccine dividend.
    Dienstag JL
    J Infect Dis; 2008 May; 197(9):1220-2. PubMed ID: 18422432
    [No Abstract]   [Full Text] [Related]  

  • 58. Hepatitis A vaccination by intracutaneous low dose administration: a less expensive alternative.
    Carlsson U; Brudin L; Eliasson I; Hansson BG
    Scand J Infect Dis; 1996; 28(5):435-8. PubMed ID: 8953668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of hepatitis A vaccination schedules on immune response.
    Tilzey AJ; Palmer SJ; Barrow S; Perry KR; Tyrell H; Safary A; Banatvala JE
    Vaccine; 1992; 10 Suppl 1():S121-3. PubMed ID: 1335640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunization of US soldiers with a two-dose primary series of inactivated hepatitis A vaccine: early immune response, persistence of antibody, and response to a third dose at 1 year.
    DeFraites RF; Feighner BH; Binn LN; Kanjarpane DD; Delem AD; MacArthy PO; Krauss MR; Krause DS; Moonsammy GI; Hoke CH
    J Infect Dis; 1995 Mar; 171 Suppl 1():S61-9. PubMed ID: 7876651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.